Identifier,Base use,Link,Phenotype,Category,n CpGs,Sample size,n Cases,n Controls,Sample type,Developmental period,Tissue,Array,Ancestry,Dimension reduction (1),Dimension reduction (2),Dimension reduction (3),Dimension reduction (4),Dimension reduction (5),Weights estimation,Internal validation,External validation,Performance,Identifier_base,Multiple_identifier_base,Sample_overlap_target_base,Comparison,Missing_value_note,Covariates
Alameda (2023) - Exploring the mediation of DNA methylation,Summary statistics,https://www.nature.com/articles/s41380-023-02044-9,Abuse,Lifestyle and environment,,,,,,Adulthood,Whole blood,EPICv1,Mixed,,,,,,,,,,,,,,,"10 principal components (PC), batch effects, site (ascertainment area where the study was conducted), gender and age "
Alameda (2023) - Exploring the mediation of DNA methylation,Summary statistics,https://www.nature.com/articles/s41380-023-02044-9,Neglect,Lifestyle and environment,,,,,,Adulthood,Whole blood,EPICv1,Mixed,,,,,,,,,,,,,,,"10 principal components (PC), batch effects, site (ascertainment area where the study was conducted), gender and age "
Alameda (2023) - Exploring the mediation of DNA methylation,Summary statistics,https://www.nature.com/articles/s41380-023-02044-9,Abuse and neglect,Lifestyle and environment,,,,,,Adulthood,Whole blood,EPICv1,Mixed,,,,,,,,,,,,,,,"10 principal components (PC), batch effects, site (ascertainment area where the study was conducted), gender and age "
Alfano (2019) - Socioeconomic position during pregnancy and,Summary statistics,https://pmc.ncbi.nlm.nih.gov/articles/PMC6443021/,Socioeconomic position,Lifestyle and environment,,,,,,Birth,Cord blood,450K,White,,,,,,,,,,,,,,,"birthweight, parity,gestational age, sex of the newborn, and technical variables: bead array row and bisulphite conversion batch."
"Antoun (2020) - Maternal dysglycaemia, changes in the infant's",Summary statistics,https://pmc.ncbi.nlm.nih.gov/articles/PMC7643947/,Gestational diabetes,Lifestyle and environment,,,,,,Birth,Cord blood,EPICv1,Mixed,,,,,,,,,,,,,,,"maternal age, smoking, ethnicity, parity, neonate sex, and the predicted values for B cells, CD4 T cells, CD8 T cells, granulocytes, monocytes,natural killer cells, and nucleated red blood cell composition. "
Appleton (2013)- Patterning in Placental 11-B hydroxysteroid dehydrogenase,Summary statistics,https://pubmed.ncbi.nlm.nih.gov/24040322/,Socioeconomic position,Lifestyle and environment,,,,,,Birth,Placenta,PCR,Mixed,,,,,,,,,,,,,,,"Maternal age, pre-pregnancy body mass index, race, infant sex and birth weight percentile"
"Carreras-Gallo (2023) - Impact of tobacco, alcohol, and",Summary statistics,https://pubmed.ncbi.nlm.nih.gov/37216580/,Alcohol consumption,Lifestyle and environment ,,,,,,Adulthood,Whole blood,EPICv1,European,,,,,,,,,,,,,,,"sex, age, ethnicity, body mass index (BMI), level of education, alcohol and tobacco consumption (except when they were the variable of interest), slide, cell type, and surrogate variables."
Chen (2017) - An epigenome-wide association study,Summary statistics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500449/,Atopic status,Physical health indicator,,,,,,Late childhood,Leukocytes,450K,Hispanic,,,,,,,,,,,,,,,"age, sex, asthma, batch (or plate), population subgroup (in GALA II) and the first five principal components (PCs) of the genotypic data, cell-types"
Dugue (2019) - Alcohol consumption is associated with,Summary statistics,https://pubmed.ncbi.nlm.nih.gov/31789449/,Alcohol consumption,Lifestyle and environment ,,,,,,Adulthood,Whole blood,450K,Australian,,,,,,,,,,,,,,,"former, <15 years ago; current, <20 cigarettes per day; current, ≥20 cigarettes per day), body mass index (BMI) (≤25, >25 to ≤30, and >30 kg/m2), country of birth (Australia/New Zealand, Italy, Greece, UK), sample type (peripheral blood mononuclear cells, dried blood spots, buffy coats), and white blood cell composition (percentage of CD4+ T cells, CD8+ T cells, B cells, NK cells, monocytes, and granulocytes, estimated using the Houseman algorithm27), and random effects for study, plate, and chip"
Everson (2015) - DNA methylation loci associated with,Summary statistics,https://pubmed.ncbi.nlm.nih.gov/26292806/,Atopic status,Physical health indicator,,,,,,Adolescence,Whole blood,450K,European,,,,,,,,,,,,,,,cell-type proportions and sex
Fang (2024) - Trans-ancestry epigenome-wide association meta-analysis,Summary statistics,https://pmc.ncbi.nlm.nih.gov/articles/PMC11078760/,Lifetime cannabis,Lifestyle and environment,,,,,,Adulthood,Peripheral blood,450K,Mixed,,,,,,,,,,,,,,,"sex, age at blood collection, blood cell proportions, and technical covariates"
Gondolia (2019) - Methylome-wide association study provides,Summary statistics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754789/pdf/nihms-1532552.pdf,PM (air polution),Lifestyle and environment ,,,,,,Adulthood,Whole blood,450K,Mixed,,,,,,,,,,,,,,,"stratified by cohort and race/ethnicity (African-, European-, and Hispanic/
Latinx-American) and adjusted for age (years) at blood draw, education (high school
education or lower, more than high school), smoking status (current, former, never), alcohol
use (current, former, never), physical activity (metabolic equivalent of task [MET-hours/
week]), body mass index (BMI, kg/m2
), neighborhood socioeconomic status (Roux et al.,
2001), mean temperature (°C), mean dew point (°C), mean barometric pressure (kPa),
season, and methylation-related variables, which included ten principal components (PCs)
for genetic ancestry (when available), leukocyte proportions, and technical covariates.
Analyses additionally controlled for cohort-specific covariates, including binary sex (male,
female) in ARIC; randomly assigned treatment group (CT subpopulations of WHI-AS311,
WHI-BAA23, WHI-EMPC); case-control status (WHI-AS311, WHI-BAA23); and control
matching criteria (WHI-AS311)."
Hannon (2016) - An integrated genetic-epigenetic analysis,Summary statistics,https://genomebiology.biomedcentral.com/articles/10.1186/s13059-016-1041-x,Schizophrenia ,Psychiatric,,,,,,Adulthood,Whole blood,450K,European,,,,,,,,,,,,,,,"age, gender, and cell composition"
Joehanes (2016) - Epigenetic Signatures of Cigarette Smoking,Summary statistics,https://www.ahajournals.org/doi/10.1161/CIRCGENETICS.116.001506,Smoking,Lifestyle and environment ,,,,,,Adulthood,Whole blood,450K,Mixed,,,,,,,,,,,,,,,"sex age blood count, technical covariates"
Joubert (2017) - DNA Methylation in Newborns and,Summary statistics,https://pubmed.ncbi.nlm.nih.gov/27040690/,Maternal smoking,Lifestyle and environment ,,,,,,Birth,Cord blood,450K,Mixed,,,,,,,,,,,,,,,"maternal age, maternal education (or a surrogate socioeconomic metric), parity, and technical covariates such as batch or plate"
Kazmi (2019) - Hypertensive disorders of pregnancy and DNA,Summary statistics,https://pmc.ncbi.nlm.nih.gov/articles/PMC6635125/pdf/hyp-74-375.pdf,Hypertensive disorders of pregnancy,Lifestyle and environment,,,,,,Birth,Cord blood,450K,Mixed,,,,,,,,,,,,,,,"adjusted for confounders [maternal age (years), parity (nulliparous vs multiparous), maternal smoking status (no smoking in pregnancy, stopped smoking in early pregnancy, smoking throughout pregnancy), diabetes mellitus (no preexisting or gestational diabetes mellitus vs prepregnancy or gestational diabetes mellitus), maternal prepregnancy body mass index (kg/m2 ), and child sex], cell proportions, and technical covariates [batch effects]"
King (2015) - Epigenetic regulation of Newborns’ imprinted ,Summary statistics,https://pmc.ncbi.nlm.nih.gov/articles/PMC4466032/pdf/nihms679913.pdf,Socioeconomic position,Lifestyle and environment,,,,,,Birth,Cord blood,PCR,Mixed,,,,,,,,,,,,,,,r race/ethnicity or SES
Knijnenburg (2019) - Genomic and molecular characterization of,Summary statistics,https://pmc.ncbi.nlm.nih.gov/articles/PMC6431191/pdf/pnas.201716314.pdf,Early preterm birth,Lifestyle and environment,,,,,,Adulthood,Whole blood,450K,Mixed,,,,,,,,,,,,,,,"maternal age, admixture coefficients, blood draw date"
Kupers (2019) - Meta-analysis of epigenome-wide,Summary statistics,https://www.nature.com/articles/s41467-019-09671-3,Birth weight,Physical health indicator,,,,,,Birth,"Multiple (Cord blood, Dried bloodspot)",450K,Mixed,,,,,,,,,,,,,,,"gestational age at delivery, child sex, maternal age at delivery, parity (0/≥1), smoking during pregnancy (no smoking/stopped in early pregnancy/smoking throughout pregnancy), pre-pregnancy BMI, socio-economic position, technical variation, and estimated white blood cell proportions (B-cells, CD8+ T-cells, CD4+ T-cells, granulocytes, NK-cells and monocytes)"
Laubach (2019) - Socioeconomic status and DNA methylation from,Summary statistics,https://pmc.ncbi.nlm.nih.gov/articles/PMC6802709/pdf/epi-11-1413.pdf,Socioeconomic position,Lifestyle and environment,,,,,,Birth,Cord blood,450K,Mixed,,,,,,,,,,,,,,,"age at enrollment, race/ethnicity, Smoking habits during pregnancy, Infant sex, Gestational age at delivery (for birth analyses), Child’s age at methylation assessment (for early and mid-childhood analyses instead of gestational age), Estimated cell type composition (cord blood reference at birth, adult leukocyte reference for later ages)"
Liu (2018) - A DNA methylation biomarker of,Summary statistics,https://www.nature.com/articles/mp2016192,Alcohol consumption,Lifestyle and environment ,,,,,,Adulthood,Whole blood,"Multiple (450K, EPICv1)",Mixed,,,,,,,,,,,,,,,"age, sex, body mass index, technical covariates and white blood cell counts; ge (continuous), sex, smoking status (never; former, ≥15 years ago"
Markunas (2016) - Maternal age at delivery is associated,Summary statistics,https://pmc.ncbi.nlm.nih.gov/articles/PMC4934688/,Maternal age at conception,Lifestyle and environment,,,,,,Birth,Cord blood,450K,European,,,,,,,,,,,,,,,"technical factors, facial cleft status, seks, birth weight, maternal alcohol use, maternal smoking, maternal edu, partiyu"
Mendelson (2017) - Association of Body Mass Index,Summary statistics,https://pubmed.ncbi.nlm.nih.gov/28095459/,BMI,Physical health indicator,,,,,,Adulthood,Whole blood,450K,White,,,,,,,,,,,,,,,"age, sex, family relatedness (random effect), and surrogate variables (to account for differential cell proportions and technical effects"
Peng (2019) - Epigenome-wide association study reveals ,Summary statistics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557548/,Allergy,Physical health indicator,,,,,,Mid childhood,Peripheral blood,450K,Mixed,,,,,,,,,,,,,,,"maternal covariates [age at enrollment (continuous), smoking status (never, former, or during pregnancy), education (college/graduate level or not college/graduate level), atopy history (asthma, eczema or hay fever)], child covariates [sex (female or male), race/ethnicity (white, black or others), gestational age (continuous)], and cell type proxies estimated for peripheral blood (percentages of monocytes, CD8T cells, CD4T cells, NK cells, and B cells)."
Portales-Casamar (2016) - DNA methylation signature of human,Summary statistics,https://epigeneticsandchromatin.biomedcentral.com/articles/10.1186/s13072-016-0074-4,Fetal alcohol syndrome,Physical health indicator,,,,,,Childhood and adolescence,Buccal cells,450K,Mixed,,,,,,,,,,,,,,,"clinical status, SVs"
Qi (2020) - Nasal DNA methylation profiling of,Summary statistics,https://www.sciencedirect.com/science/article/pii/S0091674920300348?via%3Dihub,Asthma and rihinitis,Physical health indicator,,,,,,Adolescence,Nasal epithelial cells,450K,Mixed,,,,,,,,,,,,,,," age, sex, batch, study center, and surrogate variables"
Reese (2019) - Epigenome-wide meta-analysis of,Summary statistics,https://www.sciencedirect.com/science/article/pii/S009167491832788X,Asthma,Physical health indicator,,,,,,"Birth, Childhood and adolescence",Whole blood,450K,Mixed,,,,,,,,,,,,,,,"maternal age, sustained maternal smoking during pregnancy, maternal asthma, socioeconomic status, and child's sex. Cohorts adjusted for batch effects by using ComBat or SVA or by including a batch covariate in their models."
Santos (2019) - Epigenome-wide DNA methylation in,Summary statistics,https://pmc.ncbi.nlm.nih.gov/articles/PMC6615526/pdf/kepi-14-08-1614743.pdf,Socioeconomic position,Lifestyle and environment,,,,,,Birth,Placenta,EPICv1,Mixed,,,,,,,,,,,,,,,"maternal age, maternal race (White vs. not-White), infant sex, birth weight z-score, gestational age, acute inflammation of the placenta chorion, the top 10 surrogate variables from SmartSVA to account for cell-type heterogeneity, and second-hand smoking exposure during pregnancy."
Sharp (2017) - Maternal BMI at the start of pregnancy,Summary statistics,https://pmc.ncbi.nlm.nih.gov/articles/PMC5656174/,Pre-pregnancy overweight,Lifestyle and environment,,,,,,Birth,Cord blood,450K,Mixed,,,,,,,,,,,,,,,"maternal age, maternal social class, maternal smoking status and parity, technical covariates, cell type"
Sharp (2018) - Maternal alcohol consumption and offspring,Summary statistics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753623/,Prenatal alcohol exposure,Lifestyle and environment ,,,,,,Birth,Cord blood,450K,European,,,,,,,,,,,,,,,"maternal age, maternal education, maternal smoking status, technica covariates, cord blood reference panel"
Sikdar (2019) - Comparison of smoking-related DNA,Summary statistics,https://pubmed.ncbi.nlm.nih.gov/31536415/,Maternal smoking,Lifestyle and environment ,,,,,,Birth,"Multiple (Cord blood, Whole blood)",450K,Mixed,,,,,,,,,,,,,,,"age (continuous), sex and cell-type proportion, batch effects"
Wahl (2019) - Epigenome-wide association study of,Summary statistics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570525/,BMI,Physical health indicator,,,,,,Adulthood,Whole blood,450K,Mixed,,,,,,,,,,,,,,,"Age, Sex, Physical Activity, Alcohol intake, Smoking, imputed WBC subsets, 20 control probe PCs"
Xu (2021) - Shared DNA methylation signatures in,Summary statistics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238013/,Allergy,Physical health indicator,,,,,,Childhood,Whole blood,450K,European,,,,,,,,,,,,,,,"sex, cohort, and technical covariables"
Zhang (2019) - DNA methylation and allergic sensitizations,Summary statistics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599678/,Atopic status,Physical health indicator,,,,,,Childhood and adolescence,Peripheral blood,"Multiple (450K, EPICv1)",European,,,,,,,,,,,,,,,"15 PCs, array, gender, age, cell-type"
Aref-Eshghi (2019) - Evaluation of DNA Methylation Episignatures,Validated algorithm,https://doi.org/10.1016/j.ajhg.2021.04.022,BAFopathy syndrome: no subtype specified,Genetic syndromes,140.0,889.0,140.0,749.0,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 1000,Association DNAm phenotype | AUC | top-ranking 100-150,Pruning | R-squared | 0.60-0.80,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Yes (n = 965),No actual number reported,,,,No,No,"Cell type, 10 PCs"
Aref-Eshghi (2019) - Evaluation of DNA Methylation Episignatures,Validated algorithm,https://doi.org/10.1016/j.ajhg.2020.01.019,AUTS18 syndrome / Intellectual developmental disorder with autism and macrocephaly (IDDAM),Genetic syndromes,103.0,754.0,5.0,749.0,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 1000,Association DNAm phenotype | AUC | top-ranking 100-150,Pruning | R-squared | 0.60-0.80,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Yes (n = 965),No actual number reported,,,,No,No,"Cell type, 10 PCs"
Aref-Eshghi (2019) - Evaluation of DNA Methylation Episignatures,Validated algorithm,https://doi.org/10.1016/j.ajhg.2020.01.019,CHARGE syndrome,Genetic syndromes,148.0,809.0,60.0,749.0,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 1000,Association DNAm phenotype | AUC | top-ranking 100-150,Pruning | R-squared | 0.60-0.80,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Yes (n = 965),No actual number reported,,,,No,No,"Cell type, 10 PCs"
Aref-Eshghi (2019) - Evaluation of DNA Methylation Episignatures,Validated algorithm,https://doi.org/10.1016/j.ajhg.2020.01.019,Claes-Jensen syndrome,Genetic syndromes,127.0,783.0,34.0,749.0,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 1000,Association DNAm phenotype | AUC | top-ranking 100-150,Pruning | R-squared | 0.60-0.80,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Yes (n = 965),No actual number reported,,,,No,No,"Cell type, 10 PCs"
Aref-Eshghi (2019) - Evaluation of DNA Methylation Episignatures,Validated algorithm,https://doi.org/10.1016/j.ajhg.2020.01.019,Cornelia de Lange syndrome (CdLS),Genetic syndromes,128.0,790.0,41.0,749.0,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 1000,Association DNAm phenotype | AUC | top-ranking 100-150,Pruning | R-squared | 0.60-0.80,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Yes (n = 965),No actual number reported,,,,No,No,"Cell type, 10 PCs"
Aref-Eshghi (2019) - Evaluation of DNA Methylation Episignatures,Validated algorithm,https://doi.org/10.1016/j.ajhg.2020.01.019,"Genitopatellar syndrome (GTPTS) and Ohdo syndrome, SBBYSS variant (SBBYSS)",Genetic syndromes,106.0,754.0,5.0,749.0,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 1000,Association DNAm phenotype | AUC | top-ranking 100-150,Pruning | R-squared | 0.60-0.80,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Yes (n = 965),No actual number reported,,,,No,No,"Cell type, 10 PCs"
Aref-Eshghi (2019) - Evaluation of DNA Methylation Episignatures,Validated algorithm,https://doi.org/10.1016/j.ajhg.2020.01.019,Helsmoortel–van der Aa syndrome (HVDAS) / ADNP,Genetic syndromes,105.0,768.0,32.0,749.0,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 1000,Association DNAm phenotype | AUC | top-ranking 100-150,Pruning | R-squared | 0.60-0.80,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Yes (n = 965),No actual number reported,,,,No,No,"Cell type, 10 PCs"
Aref-Eshghi (2019) - Evaluation of DNA Methylation Episignatures,Validated algorithm,https://doi.org/10.1016/j.ajhg.2020.01.019,"Intellectual developmental disorder, X-linked 93 (MRX93)",Genetic syndromes,110.0,754.0,5.0,749.0,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 1000,Association DNAm phenotype | AUC | top-ranking 100-150,Pruning | R-squared | 0.60-0.80,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Yes (n = 965),No actual number reported,,,,No,No,"Cell type, 10 PCs"
Aref-Eshghi (2019) - Evaluation of DNA Methylation Episignatures,Validated algorithm,https://doi.org/10.1016/j.ajhg.2020.01.019,Kabuki syndrome,Genetic syndromes,153.0,836.0,87.0,749.0,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 1000,Association DNAm phenotype | AUC | top-ranking 100-150,Pruning | R-squared | 0.60-0.80,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Yes (n = 965),No actual number reported,,,,No,No,"Cell type, 10 PCs"
Aref-Eshghi (2019) - Evaluation of DNA Methylation Episignatures,Validated algorithm,https://doi.org/10.1016/j.ajhg.2020.01.019,Kleefstra syndrome (Kleefstra),Genetic syndromes,107.0,769.0,20.0,749.0,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 1000,Association DNAm phenotype | AUC | top-ranking 100-150,Pruning | R-squared | 0.60-0.80,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Yes (n = 965),No actual number reported,,,,No,No,"Cell type, 10 PCs"
Aref-Eshghi (2019) - Evaluation of DNA Methylation Episignatures,Validated algorithm,https://doi.org/10.1016/j.ajhg.2020.01.019,Koolen de Vreis syndrome (KDVS),Genetic syndromes,136.0,755.0,6.0,749.0,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 1000,Association DNAm phenotype | AUC | top-ranking 100-150,Pruning | R-squared | 0.60-0.80,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Yes (n = 965),No actual number reported,,,,No,No,"Cell type, 10 PCs"
Aref-Eshghi (2019) - Evaluation of DNA Methylation Episignatures,Validated algorithm,https://doi.org/10.1016/j.ajhg.2020.01.019,Rubinstein-Taybi syndrome (RSTS),Genetic syndromes,139.0,788.0,39.0,749.0,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 1000,Association DNAm phenotype | AUC | top-ranking 100-150,Pruning | R-squared | 0.60-0.80,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Yes (n = 965),No actual number reported,,,,No,No,"Cell type, 10 PCs"
Aref-Eshghi (2019) - Evaluation of DNA Methylation Episignatures,Validated algorithm,https://doi.org/10.1016/j.ajhg.2020.01.019,Sotos syndrome,Genetic syndromes,112.0,811.0,62.0,749.0,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 1000,Association DNAm phenotype | AUC | top-ranking 100-150,Pruning | R-squared | 0.60-0.80,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Yes (n = 965),No actual number reported,,,,No,No,"Cell type, 10 PCs"
Aref-Eshghi (2019) - Evaluation of DNA Methylation Episignatures,Validated algorithm,https://doi.org/10.1016/j.ajhg.2020.01.019,Tatton–Brown–Rahman syndrome (TBRS),Genetic syndromes,139.0,763.0,14.0,749.0,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 1000,Association DNAm phenotype | AUC | top-ranking 100-150,Pruning | R-squared | 0.60-0.80,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Yes (n = 965),No actual number reported,,,,No,No,"Cell type, 10 PCs"
Aref-Eshghi (2019) - Evaluation of DNA Methylation Episignatures,Validated algorithm,https://doi.org/10.1016/j.ajhg.2020.01.019,Wiedemann-Steiner syndrome (WDSTS),Genetic syndromes,104.0,765.0,16.0,749.0,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 1000,Association DNAm phenotype | AUC | top-ranking 100-150,Pruning | R-squared | 0.60-0.80,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Yes (n = 965),No actual number reported,,,,No,No,"Cell type, 10 PCs"
Aref-Eshghi (2019) - Evaluation of DNA Methylation Episignatures,Validated algorithm,https://doi.org/10.1016/j.ajhg.2020.01.019,Williams–Beuren deletion syndrome (WBS),Genetic syndromes,82.0,770.0,21.0,749.0,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 1000,Association DNAm phenotype | AUC | top-ranking 100-150,Pruning | R-squared | 0.60-0.80,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Yes (n = 965),No actual number reported,,,,No,No,"Cell type, 10 PCs"
Aref-Eshghi (2019) - Evaluation of DNA Methylation Episignatures,Validated algorithm,https://doi.org/10.1016/j.ajhg.2020.01.019,X-linked alpha-thalassemia/mental retardation syndrome (ATRX),Genetic syndromes,101.0,767.0,18.0,749.0,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 1000,Association DNAm phenotype | AUC | top-ranking 100-150,Pruning | R-squared | 0.60-0.80,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Yes (n = 965),Reported | Specifivity/sensitivity = 100%,,,,No,No,"Cell type, 10 PCs"
Awamleh (2022) - DNA methylation signature associated with Bohring,Validated algorithm,"https://www.embase.com/search/results?subaction=viewrecord&id=L2028142302&from=export_x000D_
http://dx.doi.org/10.1038/s41431-024-01538-6",Bohrin Opitz Syndrome (BOS),Genetic syndromes,763.0,52.0,17.0,35.0,Case control,Childhood and adolescence,Peripheral blood,EPICv1,Not reported,Statistical significance | P-value | FDR < .05,Association DNAm phenotype | Actual change in methylation| 10%,,,,Penalized regression | Support vector machine,No,Yes (n = 171) ,No actual number reported,,,,No,No,"Age, sex, cell-type, DNAm age residual (from Horvath DNAm age calculator) "
Capper (2018) - DNA methylation-based classification of,Validated algorithm,https://www.nature.com/articles/nature26000,Brain tumour,Cancer,,2801.0,,,Cohort,Childhood and adolescence,Tumour cells,450K,Not reported,,,,,,Machine learning | Random forest,split 20/80; cross-valition,Yes (n = 1104),Reported | AC = .99,,,,No,No,batch
Capper (2018) - DNA methylation-based classification of,Validated algorithm,https://www.nature.com/articles/nature26000,Central nervous system tumour ,Cancer,,2801.0,,,Cohort,Childhood and adolescence,Tumour cells,450K,Not reported,,,,,,Machine learning | Random forest,split 20/80; cross-valition,Yes (n = 1104),Reported | AC = .99,,,,No,No,batch
Capper (2018) - DNA methylation-based classification of,Validated algorithm,https://www.nature.com/articles/nature26000,Glioma,Cancer,,2801.0,,,Cohort,Childhood and adolescence,Tumour cells,450K,Not reported,,,,,,Machine learning | Random forest,split 20/80; cross-valition,Yes (n = 1104),Reported | AUC = .99,,,,No,No,batch
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,ADAMTS,Biological markers,51.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Adiponectin,Biological markers,39.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Afamin,Biological markers,37.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Alpha-L-iduronidase,Biological markers,67.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Aminoacylase-1,Biological markers,395.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Beta-2-microglobulin,Biological markers,311.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,BMP1,Biological markers,67.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,CCL11,Biological markers,45.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,CCL17,Biological markers,364.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,CCL18,Biological markers,119.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,CCL21,Biological markers,98.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,CCL22,Biological markers,36.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,CCL25,Biological markers,59.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,CD163,Biological markers,151.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,CD209,Biological markers,163.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,CD48,Biological markers,17.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,CD5,Biological markers,127.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,CD6,Biological markers,41.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,CHIT1,Biological markers,111.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Coagulation factor VII,Biological markers,26.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Complement C4,Biological markers,17.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Complement C5a,Biological markers,263.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Complement C9,Biological markers,109.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Contactin-4,Biological markers,45.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,CRTAM,Biological markers,64.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,CXCL10,Biological markers,,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,CXCL11,Biological markers,,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,CXCL9,Biological markers,56.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Ectodysplasin-A,Biological markers,10.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,ENPP7,Biological markers,156.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,E-selectin,Biological markers,126.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,ESM-1,Biological markers,55.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Ezrin,Biological markers,32.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,FAP,Biological markers,74.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,FCER2,Biological markers,163.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,FCGR3B,Biological markers,102.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,FcRL2,Biological markers,38.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,FGF21,Biological markers,103.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Galectin-4,Biological markers,58.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,GCSF,Biological markers,79.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,GDF8,Biological markers,29.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,GHR,Biological markers,108.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,GPIba,Biological markers,179.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Granulysin,Biological markers,52.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Granzyme A,Biological markers,13.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,HCII,Biological markers,52.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,HGF,Biological markers,72.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,HGFA,Biological markers,20.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,HGFI,Biological markers,72.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,ICAM5,Biological markers,132.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,IGFBP1,Biological markers,120.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,IGFBP4,Biological markers,72.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,IL19,Biological markers,81.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Insulin receptor,Biological markers,51.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Lactotransferrin,Biological markers,51.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,LGALS3BP,Biological markers,186.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,L-selectin,Biological markers,99.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,LY9,Biological markers,124.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Lymphotoxin,Biological markers,67.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,MIA,Biological markers,69.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,MMP1,Biological markers,34.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,MMP12,Biological markers,257.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,MMP9,Biological markers,96.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,MRC2,Biological markers,17.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Myeloperoxidase,Biological markers,35.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,NCAM1,Biological markers,121.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,NCDase,Biological markers,50.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Neprilysin,Biological markers,34.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,NMNAT1,Biological markers,44.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,NOTCH1,Biological markers,33.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,NTRK3,Biological markers,,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Oncostatin-M,Biological markers,125.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Osteomodulin,Biological markers,180.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Pappalysin-1,Biological markers,58.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,PIGR,Biological markers,27.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,RARRES2,Biological markers,117.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Resistin,Biological markers,21.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,S100A12,Biological markers,82.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,S100A9,Biological markers,27.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,SCGF alpha,Biological markers,,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,SCGF beta,Biological markers,,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Semaphorin-3E,Biological markers,51.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,SERPINA3,Biological markers,258.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,SHBG,Biological markers,68.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Sialoadhesin,Biological markers,28.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,SKR3,Biological markers,68.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,SLITRK5,Biological markers,161.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,SMPD1,Biological markers,110.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Stanniocalcin-1,Biological markers,61.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Testican-2,Biological markers,62.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,TGF alpha,Biological markers,100.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Thrombopoietin receptor,Biological markers,41.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Thrombospondin-2,Biological markers,183.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,TNFRSF17,Biological markers,103.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,TNFRSF1B,Biological markers,83.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Trypsin-2,Biological markers,25.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,Tryptase beta-2,Biological markers,106.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,VCAM1,Biological markers,32.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,VEGFA,Biological markers,159.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2023) - Epigenetic scores for the circulating,Validated algorithm,https://elifesciences.org/articles/71802,WFIKKN2,Biological markers,66.0,1819.0,,,Population-based cohort,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,split 20/80; cross-valition,Yes (n = 9537),"Reported | r>.1, p<.05",,,,No,No,"age, sex, cohort-specific variables and, where present, cis and trans pQTL effects identified from previous analyses"
Gadd (2024) - DNAm scores for serum GDF15,Validated algorithm,https://elifesciences.org/articles/71802,GDF15,Biological markers,793.0,17489.0,,,Population-based cohort,Adulthood,Whole blood,EPICv1,European,,,,,,Penalized regression | Elastic net,cross-validation,Yes (n = 332),Reported | r = .38,,,,No,No,"age, sex and 20 genetic principal components and scaled to have a mean of 0 and variance of 1. DNAm measurements in beta format were regressed onto age, sex and processing batch and scaled to have a mean of 0 and variance of 1. Houseman immune cell estimates were included as fxed efect covariates"
Gadd (2024) - DNAm scores for serum GDF15,Validated algorithm,https://elifesciences.org/articles/71802,NTproBNP,Biological markers,383.0,16963.0,,,Population-based cohort,Adulthood,Whole blood,EPICv1,European,,,,,,Penalized regression | Elastic net,cross-validation,Yes (n = 500),Reported | r = .26,,,,No,No,"age, sex and 20 genetic principal components and scaled to have a mean of 0 and variance of 1. DNAm measurements in beta format were regressed onto age, sex and processing batch and scaled to have a mean of 0 and variance of 1. Houseman immune cell estimates were included as fxed efect covariates"
Gadd (2024) - DNAm scores for serum GDF15,Validated algorithm,https://elifesciences.org/articles/71802,GDF15,Biological markers,462.0,17489.0,,,Population-based cohort,Adulthood,Whole blood,EPICv1,European,Reproduciblity | Array | 450K only,,,,,Penalized regression | Elastic net,cross-validation,Yes (n = 332),Reported | r = .37,,,,No,No,"age, sex and 20 genetic principal components and scaled to have a mean of 0 and variance of 1. DNAm measurements in beta format were regressed onto age, sex and processing batch and scaled to have a mean of 0 and variance of 1. Houseman immune cell estimates were included as fxed efect covariates"
Gadd (2024) - DNAm scores for serum GDF15,Validated algorithm,https://elifesciences.org/articles/71802,NTproBNP,Biological markers,359.0,16963.0,,,Population-based cohort,Adulthood,Whole blood,EPICv1,European,Reproduciblity | Array | 450K only,,,,,Penalized regression | Elastic net,cross-validation,Yes (n = 500),Reported | r = .26,,,,No,No,"age, sex and 20 genetic principal components and scaled to have a mean of 0 and variance of 1. DNAm measurements in beta format were regressed onto age, sex and processing batch and scaled to have a mean of 0 and variance of 1. Houseman immune cell estimates were included as fxed efect covariates"
Jaarsveld (2023) - Delineation of a KDM2B-related neurodevelopmental,Validated algorithm,"https://www.embase.com/search/results?subaction=viewrecord&id=L2021004473&from=export_x000D_
http://dx.doi.org/10.1016/j.gim.2022.09.006",CxxC domain KM2B-related NDD,Genetic syndromes,107.0,75.0,15.0,60.0,Case control,Childhood and adolescence,Peripheral blood,EPICv1,Not reported,Association DNAm phenotype | P-value | top-ranking 1000,Association DNAm phenotype | AUC | ?,Pruning | Pairwise correlation | ?,Association DNAm phenotype | Actual change in methylation | > 5%,,Machine learning | Support vector machine,"Split 25/75%, cross-validation",Yes (unclear how many),No actual number reported,,,,No,Not reported,Cell type
Levy (2022) - Novel diagnostic DNA methylation episignatures,Validated algorithm,,22q11.2 deletion syndrome,Genetic syndromes,500.0,66.0,11.0,55.0,Case control,Childhood and adolescence,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | P-value | top-ranking ?,Statistical significance | top-ranking significant probes | ?,Association DNAm phenotype | AUC | ?,Pruning | Pairwise correlation | ?,,Machine learning | Support vector machine,"Split 25/75%, leave-25%-out-cross validation, leave-one-out-cross-validation",No,Not assessed ,,,,No,Not reported,Cell type
Levy (2022) - Novel diagnostic DNA methylation episignatures,Validated algorithm,,BAFopathy syndrome: Coffin-Siris 1-2 (CSS1-2),Genetic syndromes,500.0,44.0,4.0,40.0,Case control,Childhood and adolescence,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | P-value | top-ranking ?,Statistical significance | top-ranking significant probes | ?,Association DNAm phenotype | AUC | ?,Pruning | Pairwise correlation | ?,,Machine learning | Support vector machine,"Split 25/75%, leave-25%-out-cross validation, leave-one-out-cross-validation",No,Not assessed ,,,,No,Not reported,Cell type
Levy (2022) - Novel diagnostic DNA methylation episignatures,Validated algorithm,,Renpenning syndrome (RENS1),Genetic syndromes,329.0,64.0,8.0,56.0,Case control,Childhood and adolescence,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | P-value | top-ranking ?,Statistical significance | top-ranking significant probes | ?,Association DNAm phenotype | AUC | ?,Pruning | Pairwise correlation | ?,,Machine learning | Support vector machine,"Split 25/75%, leave-25%-out-cross validation, leave-one-out-cross-validation",No,Not assessed ,,,,No,Not reported,Cell type
Ligthart (2016) - DNA methylation signatures of chronic,Validated algorithm,https://genomebiology.biomedcentral.com/articles/10.1186/s13059-016-1119-5,C-reactive protein,Biological markers,8.0,12974.0,,,Cohort,Adulthood,Whole blood,450K,Mixed,Association DNAm phenotype | P-value | top-ranking ?,Pruning | R-squared | 0.1,,,,Discovery EWAS | Linear mixed model,No,No,Reported | Explained variance = 2.3-5.8,,,,No,Not reported,"age, sex, white blood cell proportions, technical covariates (array number and position on array), smoking (current, former and never), and BMI."
McCartney (2021) - Blood-Based Epigenome-Wide Analyses of Cognitive Abilities,Validated algorithm,,Cognitive functioning,Neuro-psychiatric health indicators,764525.0,9162.0,,,Population-based,Adulthood,Whole blood,450K,European,,,,,,Discovery EWAS | Linear mixed model,,Yes (n=844 and n=427),Reported |  correlation was3.4% (P=2.0x10-8) in LBC1936 and 4.5% (P=9.9x10-6) in LBC1921,,,,No,Mean imputed,"age, sex, BMI and an epigenetic smoking score. The DNA methylation data were corrected for batch, age, sex and epigenetic smoking, which all have pervasive effects on DNAm levels."
Mirza-Schreiber (2022) - Blood DNA methylation provides an,Validated algorithm,"https://www.embase.com/search/results?subaction=viewrecord&id=L2018091451&from=export_x000D_
http://dx.doi.org/10.1093/brain/awab360",Kabuki syndrome,Genetic syndromes,113.0,64.0,12.0,52.0,Case control,Childhood and adolescence,Peripheral blood,EPICv1,Not reported,Association DNAm phenotype | P-value | p < 5e-8,Association DNAm phenotype | Actual change in methylation | logFC > 1,,,,Machine learning | Support vector machine,Split 25/75%,"Yes (n=110,n=2278)","Reported | Specificity [99.96%, with Wilson’s 95% CI (99.72%, 100%)]; sensitivity Wilson’s 95% CI (51%, 100%). For training and test set combined, the same estimate had a 95% CI of (77%, 100%).",,,,No,No,"sex, age and Houseman"
Provencal (2020) - Glucocorticoid exposure during hippocampal neurogenesis,Validated algorithm,https://pubmed.ncbi.nlm.nih.gov/31399550/,Glucocorticoid ,Lifestyle and environment,24.0,930.0,,,Population-based,Birth,"Multiple (Whole blood, HPCs)",450K,European,Association DNAm phenotype | P-value | FDR < .1 ,Association DNAm phenotype | P-value | FDR < .01,Association DNAm phenotype | Actual change in methylation| 2%,Reproducibility | Tissue | Present in both HPC and whole bloodReproducibility across tissue | Present in both HPC and whole blood,,Penalized regression | Elastic net,Cross-validation,"Yes | CpG inclusion based in MPIP (n = 113), weights determined in (n = 817)","Reported | Linear regression | β = −0.0039, SE = 0.019, P = 0.84 (internal!)",,,,No,Not reported,"HPC: SVs; Whole blood: subject id as random factor and blood cell counts, age, gender, case-control status and BMI as fixed factor; DNAm eventual score residualized for gender, age, case-control status, bmi and blood cell counts"
Rauschert (2020) - Machine Learning-Based DNA Methylation,Validated algorithm,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491641/,Maternal smoking,Lifestyle and environment,204.0,995.0,296.0,699.0,Population-based,Adolescence,Peripheral blood,450K,European,Association DNAm phenotype | P-value | p < .00001,,,,,Penalized regression | Elastic net,80/20 train/test + Cross-validation within training,Yes (n = 517),"Reported | Sensitivity/Specifity/Cohen’s κ/Accuracy/AUC/Brierscore | sensitivity/specicity 91% and 76% internal, 87% and 75% external",,,,Yes,Reported,Not reported
Reese (2017) - DNA Methylation Score as a,Validated algorithm,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381987/,Maternal smoking,Lifestyle and environment,28.0,1278.0,168.0,110.0,Population-based,Birth,Cord blood,450K,European,Statistical significance | top-ranking significant probes | 200,,,,,Penalized regression | Lasso,80/20 train/test,No,"Reported | Accuracy, sensitivity, specificity | training set (n = 1,057; accuracy = 96%, sensitivity = 80%, specificity = 98%); test set (n = 221, sensitivity = 58%, accuracy = 91%, specificity = 97%) ",,,,Yes,Not reported,"gender, gestational age, maternal education, maternal age, parity, and the selection variable for the data set."
Richmond (2018) - DNA methylation as a marker,Validated algorithm,https://pubmed.ncbi.nlm.nih.gov/29860346/,Maternal smoking (newborns),Lifestyle and environment ,568.0,754.0,,,Population-based,Adulthood,Peripheral blood,450K,European,Association DNAm phenotype | P-value | ?,,,,,Discovery EWAS | Linear mixed model,No,"Yes (later timepoint, n=230)","Reported | AUC 0.69 [95% confidence interval (CI) 0.67, 0.73]",Joubert (2017) - DNA Methylation in Newborns and,,,No,Not reported,"Maternal age at birth and head of household social class, SVs"
Richmond (2018) - DNA methylation as a marker,Validated algorithm,https://pubmed.ncbi.nlm.nih.gov/29860346/,Maternal smoking (older children),Lifestyle and environment ,19.0,754.0,,,Population-based,Adulthood,Peripheral blood,450K,European,Association DNAm phenotype | P-value | ?,,,,,Discovery EWAS | Linear mixed model,No,"Yes (later timepoint, n=230)","Reported | AUC 0.72 (95% CI 0.69, 0.76; P for difference = 0.97)",Joubert (2017) - DNA Methylation in Newborns and,,,No,Not reported,"Maternal age at birth and head of household social class, SVs"
Stevenson (2021) - Creating and Validating a DNA,Validated algorithm,https://pubmed.ncbi.nlm.nih.gov/33595649/,IL6,Biological markers,35.0,875.0,,,Population-based,Adulthood,Whole blood,450K,European,,,,,,Penalized regression | Elastic net,No,Yes (n=7028),"Reported | R2 = 4.4%, p = 2.1 × 10-5",,,,No,Reported | removed,"age, sex, cell-type"
Turinsky (2020) - EpigenCentral: portal for DNA methylation data,Validated algorithm,,Kabuki syndrome,Genetic syndromes,,,,,Cohort,Not reported,Blood,450K,Not reported,Association DNAm phenotype | P-value | p < .05,Association DNAm phenotype | Actual change in methylation| 10%,Pruning | Pairwise correlation | ?,,,Not reported,Unclear,Unclear,Not reported,,,,No,Not reported,"Age, seks, cell type, batch"
Turinsky (2020) - EpigenCentral: portal for DNA methylation data,Validated algorithm,,Sotos syndrome,Genetic syndromes,,,,,Cohort,Not reported,Blood,450K,Not reported,Association DNAm phenotype | P-value | p < .05,Association DNAm phenotype | Actual change in methylation| 10%,Pruning | Pairwise correlation | ?,,,Not reported,Unclear,Unclear,Not reported,,,,No,Not reported,"Age, seks, cell type, batch"
Unclear - EpiSignv2,Validated algorithm,https://doi.org/10.1016/j.ajhg.2021.04.029,Angelman syndrome,Genetic syndromes,,,,,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 999,Association DNAm phenotype | AUC | top-ranking 100-149,Pruning | R-squared | 0.60-0.79,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Not reported,Not reported,,,,No,Not reported,"Cell type, 10 PCs"
Unclear - EpiSignv2,Validated algorithm,https://doi.org/10.1016/j.ajhg.2021.04.024,Velocardiofacial syndrome (VCFS),Genetic syndromes,,,,,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 999,Association DNAm phenotype | AUC | top-ranking 100-149,Pruning | R-squared | 0.60-0.79,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Not reported,Not reported,,,,No,Not reported,"Cell type, 10 PCs"
Unclear - EpiSignv2,Validated algorithm,https://doi.org/10.1016/j.ajhg.2021.04.025,Wolf-Hirschhorn syndrome (WHS),Genetic syndromes,,,,,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 999,Association DNAm phenotype | AUC | top-ranking 100-149,Pruning | R-squared | 0.60-0.79,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Not reported,Not reported,,,,No,Not reported,"Cell type, 10 PCs"
Unclear - EpiSignv2,Validated algorithm,,Beckwith-Wiedemann syndrome (BWS),Genetic syndromes,,,,,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 999,Association DNAm phenotype | AUC | top-ranking 100-149,Pruning | R-squared | 0.60-0.79,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Not reported,Not reported,,,,No,Not reported,"Cell type, 10 PCs"
Unclear - EpiSignv2,Validated algorithm,,"Blepharophimosis intellectual disability syndrome, SMARCA2 type",Genetic syndromes,,,,,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 999,Association DNAm phenotype | AUC | top-ranking 100-149,Pruning | R-squared | 0.60-0.79,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Not reported,Not reported,,,,No,Not reported,"Cell type, 10 PCs"
Unclear - EpiSignv2,Validated algorithm,,Fragile X syndrome (FXS),Genetic syndromes,,,,,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 999,Association DNAm phenotype | AUC | top-ranking 100-149,Pruning | R-squared | 0.60-0.79,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Not reported,Not reported,,,,No,Not reported,"Cell type, 10 PCs"
Unclear - EpiSignv2,Validated algorithm,,"Intellectual developmental disorder, autosomal dominant 23 (MRD23)",Genetic syndromes,,,,,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 999,Association DNAm phenotype | AUC | top-ranking 100-149,Pruning | R-squared | 0.60-0.79,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Not reported,Not reported,,,,No,Not reported,"Cell type, 10 PCs"
Unclear - EpiSignv2,Validated algorithm,,Kagami–Ogatta syndrome (KOS),Genetic syndromes,,,,,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 999,Association DNAm phenotype | AUC | top-ranking 100-149,Pruning | R-squared | 0.60-0.79,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Not reported,Not reported,,,,No,Not reported,"Cell type, 10 PCs"
Unclear - EpiSignv2,Validated algorithm,,Prader–Willi syndrome,Genetic syndromes,,,,,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 999,Association DNAm phenotype | AUC | top-ranking 100-149,Pruning | R-squared | 0.60-0.79,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Not reported,Not reported,,,,No,Not reported,"Cell type, 10 PCs"
Unclear - EpiSignv2,Validated algorithm,,Silver Russel syndrome 1 (SRS1),Genetic syndromes,,,,,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 999,Association DNAm phenotype | AUC | top-ranking 100-149,Pruning | R-squared | 0.60-0.79,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Not reported,Not reported,,,,No,Not reported,"Cell type, 10 PCs"
Unclear - EpiSignv2,Validated algorithm,,Williams–Beuren deletion syndrome (WBS) and Williams–Beuren regions duplication syndrome (Dup7),Genetic syndromes,,,,,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 1000,Association DNAm phenotype | AUC | top-ranking 100-150,Pruning | R-squared | 0.60-0.80,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Not reported,Not reported,,,,No,Not reported,"Cell type, 10 PCs"
Unclear - EpiSignv2,Validated algorithm,,KBG syndrome,Genetic syndromes,,,,,Case control,Not reported,Peripheral blood,"Multiple (450K, EPICv1)",Not reported,Association DNAm phenotype | effect size,Statistical significance | top-ranking significant probes | 1000,Association DNAm phenotype | AUC | top-ranking 100-150,Pruning | R-squared | 0.60-0.80,,Penalized regression | Support vector machine,"Split 25/75%, 10-fold cross-validation",Not reported,Not reported,,,,No,Not reported,"Cell type, 10 PCs"
Wahl (2019) - Epigenome-wide association study of,Validated algorithm,,BMI,Physical health indicator,187.0,10261.0,,,Population-based,Adulthood,Whole blood,450K,Mixed,Association DNAm phenotype | P-value | p < 1e-7,Pruning | Location | 500kb,,,,Discovery EWAS | Linear mixed model,Split 50-50,No,"Reported | RR | 7.3 (95% CI: 4.1–12.9), P = 8.2 × 10⁻¹",,,,No,Not reported,"Age, Sex, Physical Activity, Alcohol intake, Smoking, imputed WBC subsets, 20 control probe PCs"
Wielscher (2022) - DNA methylation signature of chronic low-grade inflammation,Validated algorithm,,C-reactive protein,Biological markers,1511.0,22774.0,,,Population-based,Adulthood,Whole blood,"Multiple (450K, EPICv1)",Mixed,Association DNAm phenotype | P-value | p < 1e-7,Pruning | Location | 5kb,,,,Discovery EWAS | Linear mixed model,No,No,Not reported,,,,No,Not reported,"r age, sex, blood cell type composition and technical confounders"
